Dr. Artem Cherkasov, Co-Founder and President of Artemis Therapeutics, delivered an invited lecture titled “DeepDocking in Drug Discovery – Clinical Examples” at the Canadian Conference on Ovarian Cancer Research (CCOCR), held in Vancouver, British Columbia, from May 29 to June 1, 2026.
The presentation addressed the application of DeepDocking technology to drug discovery, including examples relevant to clinical research.
DeepDocking™, the AI-accelerated virtual screening platform pioneered by Dr. Cherkasov, forms part of the scientific foundation of Artemis Therapeutics and its approach to identifying promising small-molecule therapeutic candidates.